At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 203 enrolled
Drug / intervention
Celecoxib 400 mg +3 moredrug
Likely dose
Celecoxib 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars
In Brief
A Phase 2 clinical trial evaluating Celecoxib 400 mg, Placebo, and 2 other interventions for Dental Pain. Completed, enrolled 203 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2009
First PostedAug 2009
Primary CompletionDec 2009
TodayJul 2026
First PostedAug 25, 2009
Enrollment StartAug 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.9 years ago
Interventions
Celecoxib 400 mgdrug
Capsules 2 x 200 mg Single-Dose
Placebodrug
Capsules 2 Single-Dose
Indomethacin Test (lower dose)drug
20-mg single dose
Indomethacin Test (upper dose)drug
40-mg single dose